This case report describes an eight-year-old Kashmiri boy diagnosed with monilethrix, a rare genetic hair disorder, characterized by a beaded appearance and fragility of the hairshaft.
6 citations
,
January 2008 in “Indian Journal of Dermatology”
This case report describes a rare autosomal dominant hairshaft disorder, monilethrix, observed in three consecutive generations of a family, with gradual improvement noted with age.
June 2011 in “European Journal of Pediatric Dermatology”
This study diagnosed an 11-year-old girl with initial androgenetic alopecia and monilethrix after observing unique hairshaft abnormalities and skin conditions, unlike her affected parents.
In this clinical case study, a 9-year-old girl was diagnosed with monilethrix, a hereditary hairshaft disorder characterized by weak, beaded hair, with management focusing on minimizing hair trauma.
The conversation discusses differences in hairshaft diameter and density between thinning and denser areas on the scalp. Treatments mentioned include Minoxidil, finasteride, and dutasteride.
The FDA policy change may speed up approval for hair loss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.
Exosomes from mesenchymal stem cells can increase hair growth by enhancing anagen duration and hairshaft thickness through the Wnt/beta-catenin pathway. Phase 2 trials show improved hair counts over 24 weeks.
Microneedling should target depths of 0.5mm to 1.5mm for hair loss, with weekly sessions at 1mm recommended. Combining microneedling with Minoxidil is common for improved results.
Finasteride users reported improvements in hair appearance, including increased thickness, shine, and darker color. Some users noticed their hair looked healthier and less sunburned after starting the treatment.
How does cetirizine reduce inflammation linked to hair loss?Cetirizine is proposed to lower prostaglandin D2 and raise prostaglandin E2 around hair follicles; three small trials of a compounded 1% topical report modest increases in hair density and shaft thickness, with minoxidil doing better head-to-head. Topical cetirizine is off-label and unapproved for hair loss, and the evidence is too thin to call it effective or safe.